When a Label Becomes a Lifeline

FineLine acquires Digi-Trax, adding ISBT-128 hospital labeling expertise to its global supply chain network

3 Jun 2026

When blood, tissue, or cellular therapy material moves from collection to patient care, the label on it carries more weight than most people realise. FineLine Technologies has acquired Digi-Trax, a 40-year specialist in hospital and blood centre identification systems, folding ISBT-128 compliant labeling technology into one of the world's largest label and RFID manufacturing networks.

Digi-Trax's platforms track sterile medical products across their full journey, integrating with hospital IT and laboratory systems at multiple institutions. Founded on deep domain knowledge, the business now operates as FineLine's new Healthcare Division. Its owner, Jeff Kriozere, stays on to lead it.

The scale behind the acquisition is significant. FineLine serves more than 85,000 registered suppliers and distributes billions of labels annually through its global hub network. That reach gives Digi-Trax's healthcare expertise a distribution backbone it never had before.

Across Europe, the compliance pressure is real and building. EU Blood Directive requirements and expanding cell therapy pipelines are forcing hospitals and blood centres to upgrade identification systems that have long lagged behind clinical ambition. ISBT-128 standardisation, once considered best practice, is now a practical prerequisite for institutions that need interoperability, audit readiness, and cross-border data integrity.

For facilities navigating that shift, the combined offer is well-timed. Demand for standards-aligned identification is accelerating, and scale now sits directly behind the expertise to meet it.